Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia
- Resource Type
- Article
- Source
- In
Clinical and Translational Radiation Oncology May 2022 34:7-14 - Subject
- Language
- ISSN
- 2405-6308